Yannick Marchalant, Ph.D. - Publications

2014- Psychology Central Michigan University, Mount Pleasant, MI, United States 
Aging, Alzheimer's disease

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Keene J, Granett BA, Crombez EM, Marchalant Y. Deciphering The Role Of Neuroinflammation In The Early Events Of Alzheimer'S Disease Alzheimers & Dementia. 12: 861. DOI: 10.1016/J.Jalz.2016.06.1768  1
2015 Bonnet AE, Marchalant Y. Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer's Disease. Aging and Disease. 6: 400-5. PMID 26425394 DOI: 10.14336/AD.2015.0617  1
2015 Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease. Cellular and Molecular Life Sciences : Cmls. PMID 26202697 DOI: 10.1007/S00018-015-1992-1  1
2015 Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, Py NA, Bernard A, Bauer C, Charrat E, Moschke K, Seiki M, Vignes M, Lichtenthaler SF, Checler F, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease Cellular and Molecular Life Sciences. DOI: 10.1007/s00018-015-1992-1  1
2014 Py NA, Bonnet AE, Bernard A, Marchalant Y, Charrat E, Checler F, Khrestchatisky M, Baranger K, Rivera S. Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. Frontiers in Aging Neuroscience. 6: 247. PMID 25278878 DOI: 10.3389/Fnagi.2014.00247  1
2014 Marchalant Y, Brownjohn PW, Bonnet A, Kleffmann T, Ashton JC. Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 62: 395-404. PMID 24670796 DOI: 10.1369/0022155414530995  1
2013 Brothers HM, Bardou I, Hopp SC, Marchalant Y, Kaercher RM, Turner SM, Mitchem MR, Kigerl K, Wenk GL. Time-Dependent Compensatory Responses to Chronic Neuroinflammation in Hippocampus and Brainstem: The Potential Role of Glutamate Neurotransmission. Journal of Alzheimer's Disease & Parkinsonism. 3: 110. PMID 24600537 DOI: 10.4172/2161-0460.1000110  1
2013 Crouzin N, Baranger K, Cavalier M, Marchalant Y, Cohen-Solal C, Roman FS, Khrestchatisky M, Rivera S, Féron F, Vignes M. Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus. Plos One. 8: e74667. PMID 24069328 DOI: 10.1371/Journal.Pone.0074667  1
2012 Marchalant Y, Baranger K, Wenk GL, Khrestchatisky M, Rivera S. Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? Journal of Neuroinflammation. 9: 10. PMID 22248015 DOI: 10.1186/1742-2094-9-10  1
2012 Bardou I, DiPatrizio N, Brothers HM, Kaercher RM, Baranger K, Mitchem M, Hopp SC, Wenk GL, Marchalant Y. Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging Health. 4: 679-684. DOI: 10.4236/Health.2012.429107  1
2010 Brothers HM, Marchalant Y, Wenk GL. Caffeine attenuates lipopolysaccharide-induced neuroinflammation. Neuroscience Letters. 480: 97-100. PMID 20541589 DOI: 10.1016/j.neulet.2010.06.013  1
2009 Marchalant Y, Brothers HM, Wenk GL. Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain. Molecular Psychiatry. 14: 1068-9. PMID 19920834 DOI: 10.1038/mp.2009.62  1
2009 Marchalant Y, Brothers HM, Wenk GL. New neuron production can be increased in the hippocampus of aged rats following cannabinoid treatment. Molecular Psychiatry. 14: 1067, 1068-9. PMID 19920833 DOI: 10.1038/mp.2009.122  1
2009 Marchalant Y, Brothers HM, Norman GJ, Karelina K, DeVries AC, Wenk GL. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis. Neurobiology of Disease. 34: 300-7. PMID 19385063 DOI: 10.1016/J.Nbd.2009.01.014  1
2008 Marchalant Y, Brothers HM, Wenk GL. Inflammation and aging: can endocannabinoids help? Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 62: 212-7. PMID 18400455 DOI: 10.1016/j.biopha.2008.02.004  1
2008 Marchalant Y, Cerbai F, Brothers HM, Wenk GL. Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Neurobiology of Aging. 29: 1894-901. PMID 17561311 DOI: 10.1016/J.Neurobiolaging.2007.04.028  1
2008 Brothers H, Cerbai F, Marchalant Y, Wenk G. P3-353: Regional susceptibility to inflammation: Neuron-glia interactions in the hippocampus and substantia nigra and rescue by the NMDA antagonist memantine Alzheimer's & Dementia. 4: T625-T625. DOI: 10.1016/J.Jalz.2008.05.1923  1
2008 Marchalant Y, Brothers HM, Wenk GL. P2-398: Role Of endocannabinoids on neuroinflammation, memory and neurogenesis in aged rats Alzheimer's & Dementia. 4: T489-T490. DOI: 10.1016/j.jalz.2008.05.1476  1
2007 Marchalant Y, Rosi S, Wenk GL. Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neuroscience. 144: 1516-22. PMID 17178196 DOI: 10.1016/j.neuroscience.2006.11.016  1
2004 Barbelivien A, Vaussy C, Marchalant Y, Maubert E, Bertrand N, Beley A, Roussel S, Mackenzie ET, Dauphin F. Degeneration of the basalocortical pathway from the cortex induces a functional increase in galaninergic markers in the nucleus basalis magnocellularis of the rat. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 24: 1255-66. PMID 15545921 DOI: 10.1097/01.Wcb.0000139447.69413.05  1
2000 Gsell W, De Sadeleer C, Marchalant Y, MacKenzie ET, Schumann P, Dauphin F. The use of cerebral blood flow as an index of neuronal activity in functional neuroimaging: experimental and pathophysiological considerations. Journal of Chemical Neuroanatomy. 20: 215-24. PMID 11207420 DOI: 10.1016/S0891-0618(00)00095-8  1
Show low-probability matches.